Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic HSCT for Severe Osteopetrosis
NCT00775931Phase 3Completed
- Sponsor
- Masonic Cancer Center
- Start
- Aug 2008
- Primary completion
- Jun 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic hematopoietic stem cells in osteopetrosis, sponsored by Masonic Cancer Center. Started Aug 2008; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
osteopetrosis
Beyond the preview
Go deeper on NCT00775931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775931.